KR20070111765A - Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing - Google Patents
Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing Download PDFInfo
- Publication number
- KR20070111765A KR20070111765A KR1020060044961A KR20060044961A KR20070111765A KR 20070111765 A KR20070111765 A KR 20070111765A KR 1020060044961 A KR1020060044961 A KR 1020060044961A KR 20060044961 A KR20060044961 A KR 20060044961A KR 20070111765 A KR20070111765 A KR 20070111765A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- growth
- golden
- hair
- dermal papilla
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims description 14
- 210000004209 hair Anatomy 0.000 title abstract description 18
- 239000002075 main ingredient Substances 0.000 title description 2
- 230000002500 effect on skin Effects 0.000 claims abstract description 47
- 230000003779 hair growth Effects 0.000 claims abstract description 40
- 230000014509 gene expression Effects 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 19
- 230000001737 promoting effect Effects 0.000 claims abstract description 19
- 239000003102 growth factor Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 238000012216 screening Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 201000004384 Alopecia Diseases 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 230000003676 hair loss Effects 0.000 claims abstract description 8
- 208000024963 hair loss Diseases 0.000 claims abstract description 8
- 239000002953 phosphate buffered saline Substances 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims abstract description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims abstract description 7
- 230000010261 cell growth Effects 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims abstract description 3
- 238000004108 freeze drying Methods 0.000 claims abstract description 3
- 230000001954 sterilising effect Effects 0.000 claims abstract 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 12
- 239000010931 gold Substances 0.000 claims description 12
- 229910052737 gold Inorganic materials 0.000 claims description 12
- 241000700159 Rattus Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 15
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 6
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 6
- 239000012141 concentrate Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 68
- 230000001965 increasing effect Effects 0.000 description 13
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 11
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 11
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 11
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 11
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 11
- 230000003658 preventing hair loss Effects 0.000 description 8
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229960003632 minoxidil Drugs 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000010534 mechanism of action Effects 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 244000286916 Ratibida columnifera Species 0.000 description 3
- 235000009413 Ratibida columnifera Nutrition 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000699800 Cricetinae Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101000997803 Homo sapiens Glia-derived nexin Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 210000002768 hair cell Anatomy 0.000 description 2
- 230000003659 hair regrowth Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 1
- 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102100033299 Glia-derived nexin Human genes 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001077898 Melanthera Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 244000170475 Saraca indica Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241000800728 Stereodon fauriei Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000003317 double-positive, alpha-beta immature T lymphocyte Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
도 1은 분리한 모유두세포의 alkaline phosphatase 활성도 측정결과를 나타내는 도면, 1 is a view showing the results of alkaline phosphatase activity measurement of isolated dermal papilla cells,
도 2는 분리한 모유두세포의 유전자발현조사결과를 나타내는 도면,Figure 2 is a diagram showing the results of gene expression investigation of isolated dermal papilla cells,
도 3은 모유두세포에서의 유전자발현 측정결과를 나타내는 도면.Figure 3 shows the results of gene expression measurement in dermal papilla cells.
본 발명은 황금추출물와 그를 주성분으로 하는 발모촉진제 및 발모촉진 효과 유무의 검사 방법에 관한 것으로, 특히 한국의 천연자생식물인 황금으로부터 얻은 추출물와 그를 주성분으로 하는 발모 촉진제 및 식물 추출물에 대한 발모촉진 효과 유무의 검사 방법에 관한 것이다.The present invention relates to a golden extract and a method for inspecting the hair growth promoting agent and hair growth promoting effect as a main component, in particular the extract obtained from gold, a natural native plant of Korea and hair growth promoting agent and plant extract as a main component It is about a test method.
환경적 요인과 과다한 스트레스에 노출되어 있는 현대인들의 탈모발생 빈도는 높아지고 있으며, 대인관계와 외모를 중시하는 현대 사회의 풍토로 인해 그로 인한 문제점들이 많이 지적되고 있는 상황이다. 이러한 추세로 인해 발모제에 대한 수요와 시장성은 매우 커지고 있으나 관련 분야의 기초적인 연구는 매우 미흡한 상황이다. 전 세계적으로 가장 많이 사용되고 있는 미녹시딜(Minoxidil)의 경우 30년 이상 활용되고 있음에도 불구하고 작용범위와 기전이 아직도 모두 밝혀지지 않은 상태이다. 새로운 발모제의 개발은 탈모와 발모에 관련된 작용기전을 분자적 수준에서 이해하고 각 작용기점에서 활성을 조절할 수 있는 물질의 검색을 통해 이루어질 수 있다. 특히 임상에서 적용할 수 있는 효과적인 발모제 개발을 위해서는 전임상실험의 결과를 예측할 수 있는 적합한 시스템의 구축이 필수불가결하다 할 수 있다. 기존에는 효능이 있을 것으로 예측되는 물질을 실험동물에 도포하여 털이 자라는 정도를 관찰함으로써 일차적으로 발모에 효과적인 기능성 물질을 선별하는 방법을 취하였다. The incidence of hair loss in modern people who are exposed to environmental factors and excessive stress is increasing, and many of the problems are pointed out due to the climate of modern society that emphasizes interpersonal relationships and appearance. Due to this trend, the demand and marketability of hair regrowth are growing very much, but the basic research in related fields is very insufficient. Minoxidil, the most widely used worldwide, has been used for more than 30 years, but its range and mechanism are still unknown. The development of new hair growth agents can be achieved through the understanding of the mechanism of action related to hair loss and hair growth at the molecular level and the search for substances that can regulate activity at each point of action. In particular, in order to develop an effective hair repellent that can be applied in clinical practice, it is essential to establish a suitable system for predicting the results of preclinical studies. Conventionally, by applying a substance that is expected to be effective to the experimental animal to observe the degree of hair growth, the first method was to select a functional substance effective for hair growth.
이러한 방법은 다량의 시료의 효능을 동시에 관찰하는 것이 매우 어려우며, 장시간의 관찰과 실험동물 사육에 따른 비용을 감수해야 하는 단점을 가지고 있다. 또한 현상적으로 털이 나는 상태를 관찰할 수는 있으나 개체간의 차이를 감수해야 하며, 그 작용기전을 살펴보기 위해서는 조직을 취하거나 별도의 연구를 수행해야 하는 과정이 뒤따라야 한다. This method is very difficult to observe the efficacy of a large amount of samples at the same time, has the disadvantage of having to pay the cost of long-term observation and laboratory animal breeding. Phenomenologically hairy conditions can be observed, but individual differences must be taken, and the mechanism of action must be followed by the process of taking tissue or conducting a separate study.
따라서 보다 효과적으로 작용기전을 관찰하고 빠른 시간내에 효능물질을 검색하기 위해서는 발모와 직접적으로 관련 있는 세포의 사용이 매우 유용할 것으로 사료된다. Therefore, in order to observe the mechanism of action more effectively and search for agonists in a short time, the use of cells directly related to hair growth may be very useful.
또한 이러한 발모촉진제에 관한 일 예가 대한민국 특허공개공보 2001- 0010655호(2001년02월15일) 등에 개시되어 있다.In addition, an example of such a hair promoter is disclosed in Korean Patent Publication No. 2001- 0010655 (February 15, 2001).
즉, 상기 문헌에 있어서는 참깨꽃 추출물 및 트레티노인을 유효 성분으로하는 모발 성장 조성물에 대해 제시하고 있다.That is, in the above document, a hair growth composition containing sesame flower extract and tretinoin as an active ingredient is proposed.
또한 발모촉진을 위하여 황금 물 추출물을 포함하여 국내 자생추출물의 사용이 빈번하나 대부분 구체적 작용 원리가 규명되어 있지 않다. In addition, although Korean native extracts, including golden water extracts, are frequently used to promote hair growth, most of the specific principles of action have not been elucidated.
따라서 이러한 배경 하에 본 발명의 발명자들은 황금 추출물이 탈모 방지 및 발모 촉진에 효과를 가짐을 확인하였는바 인위적인 합성물이 아닌 자연 식물성 추출물을 이용한 본 발명은 부작용없는 발모촉진제로서 활용도가 높을 것이다.Therefore, the inventors of the present invention under these backgrounds have confirmed that the golden extract has an effect on hair loss prevention and hair growth promotion, the present invention using natural plant extracts rather than artificial compounds will have high utility as a hair growth promoter without side effects.
이에 본 발명자들은 탈모 및 발모 작용기전을 쉽게 관찰할 수 있도록 적합한 세포로서 생후 2일된 랫트로부터 모유두 세포를 분리하고 배양하여 스크리닝에 이용하였다. Thus, the present inventors isolated and cultured the dermal papilla cells from the two-day-old rats as suitable cells so that hair loss and hair growth mechanisms can be easily observed, and used for screening.
본 발명의 목적은 상술한 바와 같은 문제점을 해결하기 위해 이루어진 것으로서, 모유두세포의 성장을 촉진시키는 인자들의 발현증가를 통해 모유두세포의 성장을 초래하여 종래에는 모발의 퇴행지연 및 발모촉진을 유도하는 황금추출물 및 그를 주성분으로 하는 발모촉진제, 그리고 발모촉진 효과 유무의 검사 방법을 제공하는 것이다.An object of the present invention has been made to solve the problems described above, causing the growth of dermal papilla cells through the increase in the expression of factors that promote the growth of dermal papilla cells, conventionally inducing hair retardation and hair growth promotion gold It is to provide an extract, a hair promoter having a main ingredient thereof, and a test method for the presence or absence of hair growth promoting effect.
본 발명의 다른 목적은 천연식물로부터 유래되어 인체에 무독하며 부작용이 없는 발모 촉진제를 제공하는 것이다.Another object of the present invention is to provide a hair growth promoting agent which is derived from natural plants and is non-toxic to humans.
본 발명의 다른 목적은 모유두세포의 성장을 촉진시키는 인자들의 발현증가를 통해 모유두세포의 성장을 초래할 수 있는 효과를 가지는 식물 추출물을 스크리닝하는 것에 의해 탈모 방지 및 발모촉진 효과를 검사할 수 있는 방법을 제공하는 것이다.Another object of the present invention is to examine a method for examining the effect of hair loss prevention and hair growth by screening plant extracts having the effect of causing the growth of dermal papilla cells by increasing the expression of factors that promote the growth of dermal papilla cells. To provide.
상기 목적을 달성하기 위해 본 발명에 따른 황금 조성물의 추출 방법은 건조된 황금을 마련하는 단계, 상기 건조된 황금1kg에 대해 5배의 물로 열추출하여 여과하는 단계, 상기 여과하는 단계에서의 여액을 감압 농축 후 72시간 동결 건조하는 단계, 상기 건조하는 단계에서의 황금 열 수추출물에 대해 PBS(Phosphate buffered saline)를 사용하여 최종 농도 10㎎/㎖가 되도록 용해시키는 단계 및 상기 용해 단계에서 용해된 액을 필터로 여과하고 멸균하여 황금 조성물을 추출하는 단계를 포함하는 것을 특징으로 한다.In order to achieve the above object, the extracting method of the golden composition according to the present invention comprises the steps of preparing dried gold, heat extraction with 5 times of water with respect to 1 kg of dried gold, and filtering the filtrate in the filtering step. Freeze-drying for 72 hours after concentration under reduced pressure, dissolving the golden hot water extract in the drying step to a final concentration of 10 mg / ml using PBS (Phosphate buffered saline) and the solution dissolved in the dissolution step To filter and sterilize the filter characterized in that it comprises the step of extracting the golden composition.
또 본 발명에 있어서는 상기 황금 조성물의 추출 방법에 의해 추출된 황금추출물인 것을 특징으로 한다.In the present invention is characterized in that the golden extract extracted by the extraction method of the golden composition.
또 본 발명에 있어서는 상기 황금추출물을 주성분으로 하는 발모촉진제인 것을 특징으로 한다.In addition, the present invention is characterized in that it is a hair growth promoter containing the golden extract as a main component.
또 본 발명에 있어서는 상기 황금추출물을 주성분으로 하는 양모제인 것을 특징으로 한다.In the present invention, it is characterized in that the wool extract containing the golden extract as a main component.
또 본 발명에 있어서는 상기 황금추출물을 주성분으로 하는 육모제인 것을 특징으로 한다.In addition, the present invention is characterized in that it is a hair restorer containing the golden extract as a main component.
또한 상기 목적을 달성하기 위해 본 발명에 따른 발모촉진 효과 유무의 검사 방법은 생후 2일 된 랫트로부터 모유두세포를 분리하여 세포생장 및 성장인자의 발현을 측정함으로써 탈모를 방지하고 발모를 촉진하는 황금추출물을 스크리닝하는 것을 특징으로 한다.In addition, the test method of the hair growth promoting effect according to the present invention in order to achieve the above object is isolated from the dermal papilla cells from the 2 days old rats by measuring the growth and expression of growth factors to prevent hair loss and promote hair growth It is characterized by screening.
본 발명의 상기 및 그 밖의 목적과 새로운 특징은 본 명세서의 기술 및 첨부 도면에 의해 더욱 명확하게 될 것이다.The above and other objects and novel features of the present invention will become more apparent from the description of the specification and the accompanying drawings.
먼저 본 발명의 개념에 대해 설명한다.First, the concept of the present invention will be described.
본 발명의 발명자들은, 황금의 열 수 추출물을 대상으로 모유두세포의 성장 촉진 및 관련인자들의 발현 증가를 측정하여 인바이트로(in vitro)에서의 탈모 방지 및 발모촉진효과를 증명함으로써 본 발명을 완성하였다.The inventors of the present invention completed the present invention by demonstrating the effect of preventing hair loss and promoting hair growth in vitro by measuring growth promotion of hair papilla cells and increased expression of related factors in golden hydrothermal extract. .
황금(Scutellaria baicalensis)은 꿀풀과(―科 Lamiaceae)에 속하는 다년생초로서, 전국 각지의 산 기슭에서 자라며 약초로도 재배되고 있다. 키는 약 60㎝이고 여러 개의 네모진 줄기가 뿌리에서 나오며, 피침형의 잎은 마주나고 가장자리는 밋밋하고, 입술 모양의 자주색 꽃은 7~8월경 줄기 끝에서 총상(總狀)꽃차례를 이루며 핀다. 열매는 꽃받침 안에 있으며 둥글다. 한국에는 골무꽃속(―屬Scutellaria)의 골무꽃(S. indica), 그늘골무꽃(S. fauriei)을 비롯해 10여 종(種)이 자생하고, 이 풀의 뿌리를 한방에서 사용하며, 씨로 번식한다. Golden (Scutellaria baicalensis) is a perennial herb belonging to the Lamiaceae family. It grows at the foot of the mountain and is grown as a herb. Its height is about 60cm and several square stems come out from the root, lanceolate leaves face each other, the edges are flat, and the lip-shaped purple flowers bloom in July-August at the end of the stem. . The fruit is in the calyx and is round. In Korea, there are about 10 species, including the thimble flower (S. indica) and the thimble flower (S. fauriei) of the thimble flower (―Scutellaria). do.
이 황금은 열을 내리고 해독의 목적으로 자주 사용되는 약재로서 뿌리를 채 취하여 뿌리 껍질을 벗겨보면 황금(黃金)과 같이 노란색깔을 띄며, 몸에 열독이 오르거나 오한 등이 잦은 것을 치료하는데, 주로 폐에 열로 인한 증상에 다용(多用)되고, 열로 인한 갈증과 황달, 이질, 설사, 소화불량, 황련과 마찬가지로 몸에 있는 종기나 종양, 더욱 더 심해져서 생기는 등창들을 치료한다. 특이하게 일반적으로 쓰이고 차가운 약은 임산부에게는 금지하여야 할 약재로 분류되는데, 황금의 경우 볶으면 임신중 태동불안 등으로 괴로움을 겪을 때에도 좋은 치료 효과가 있는 것으로 알려있다.This is a medicinal herb that is often used for the purpose of lowering heat and detoxification. When taking the root and peeling the root, it is yellowish like golden (黃 金) and treats frequent heat poisoning or chills in the body. It is used for the symptoms of heat in the lungs, and it treats boils and tumors in the body, such as thirst and jaundice, dysentery, diarrhea, indigestion, and nausea caused by fever. Unusually commonly used and cold medicine is classified as a medicine that should be prohibited to pregnant women, if the golden fry is known to have a good therapeutic effect even when suffering from pregnancy anxiety.
즉, 본 발명에서는 상술한 바와 같은 황금을 이용하는 것이다.That is, in the present invention, gold as described above is used.
본 발명의 발명자들은 위와 같은 황금 추출물이 모유두세포의 성장 촉진 및 관련인자들 즉, VEGF(Vascular Endothelial Growth Factor) 및 KGF(Keratinocyte Growth Factor), IGF(Insulin Growth Factor)의 발현 증가를 측정하여 인바이트로(in vitro)에서의 탈모 방지 및 발모촉진효과를 확인하고, 이로부터 황금 추출물을 탈모 방지 및 발모촉진제의 소재로 활용하는 본 발명을 안출하였다.The inventors of the present invention measured the growth of the dermal papilla cells and the related factors, namely VEGF (Vascular Endothelial Growth Factor), KGF (Keratinocyte Growth Factor), IGF (Insulin Growth Factor) by measuring the expression of in vitro To determine the effect of hair loss prevention and hair growth in (in vitro), from the present invention was devised a gold extract as a material for hair loss prevention and hair growth promoting agent.
한편 본 발명에서 활용한 탈모방지 및 발모 촉진효과 스크리닝 방법은 모유두세포의 성장촉진 및 성장인자발현 증가를 측정함으로써 이루어지며 이들 방법은 스크리닝 및 작용기전을 동시에 증명할 수 있는 시험법이다.Meanwhile, the hair loss prevention and hair growth promoting screening method utilized in the present invention is made by measuring growth promotion and growth factor expression increase of dermal papilla cells, and these methods are test methods that can simultaneously prove screening and mechanism of action.
모발은 피부 속에 3-5㎜ 정도 묻혀 표피와 진피에 쌓이게 되는데 이 부분을 모포라고 한다. 모포 위에 털을 지배하는 조직인 모유두(Dermal papilla)가 있으며, 이 모유두 바로 위에 털을 만들어 내는 모모세포가 있어 분열을 계속하면서 새로운 털을 생산하여 위로 밀어 올린다. 모유두세포는 성장이 활발한 생장 기(anagen), 퇴행이 시작되는 퇴행기(catagen), 휴지기(telogen)의 주기를 가지고 있으며, 휴지기 이후에 인접세포로부터 신호를 전달받으면 다시 성장기로 접어들어 세포의 재생성이 이루어지며 결과적으로 새로운 모발의 생성으로 나타나게 된다. The hair is buried about 3-5mm in the skin and accumulated on the epidermis and dermis. This part is called a blanket. There is dermal papilla, the tissue that controls the hairs on top of the follicles, and there are hair cells that make the hairs just above the papillas and continue to divide, producing new hairs and pushing them up. The dermal papilla cells have a period of active growth, anagen, catagen, and telogen cycles, and when signals are received from adjacent cells after the resting phase, they enter the growth phase and regenerate the cells. This results in the formation of new hair.
이러한 정상적인 주기에 관여하는 세포신호전달 및 관련분자의 유전자발현과 활성에 영향이 미치게 되면 탈모 및 모발 굵기의 변화 등이 나타나게 된다. 모유두 세포는 중배엽에서 유래되며, 현재까지는 섬유아세포와 가장 유사한 세포로 알려지고 있다. 또한 생체내 모유두세포 특이적인 표식자로서 versican이 보고 되어 있으며, versican을 발현하는 모유두세포는 모발 유도능을 갖는다는 것이 기존에 알려진 바이다.Hair loss and hair thickness change appear when the cell signal transduction and gene expression and activity of related molecules are affected. The dermal papilla cells are derived from mesoderm and are known to be the most similar to the fibroblasts. In addition, versican has been reported as a specific marker of dermal papilla cells in vivo, and it is known that dermal papilla cells expressing versican have hair inducing ability.
이에 본 발명자들은 생후 2 일된 랫트로부터 모유두세포를 분리하였으며, 분리된 세포에서 versican 표식자를 확인하여 발모촉진효과 측정에 사용하였다. Thus, the present inventors separated the dermal papilla cells from the rats 2 days old, and used the versican markers in the isolated cells to measure the hair growth promoting effect.
모유두세포의 성장은 여러 가지 성장인자들에 의해서 이루어진다. 대표적인 성장인자로서 VEGF(Vascular endothelial growth factor)와 KGF(keratinocyte growth factor), IGF(Insulin Growth Factor)가 있는데 이들 성장인자의 증가는 모유두세포의 성장을 유지에 중요하다. 이들 성장인자의 발현 증가를 통해 모유두세포의 성장 유도는 종래에 모발세포주기 중 성장기의 유지 및 퇴행기 지연의 효과를 가짐으로써 탈모방지 및 발모촉진을 유도될 수 있다. Growth of dermal papilla cells is caused by various growth factors. Representative growth factors include VEGF (Vascular endothelial growth factor), KGF (keratinocyte growth factor), and IGF (Insulin Growth Factor). These growth factors are important for maintaining the growth of dermal papilla cells. Induction of growth of the dermal papilla cells through increased expression of these growth factors can induce hair loss prevention and hair growth by conventionally having the effects of maintaining the growth phase and delaying the degenerative phase of the hair cell cycle.
이에 본 발명자들은 분리한 모유두세포에 황금추출물을 처리한 후 VEGF와 KGF, IGF의 발현 증가를 확인하였다.Therefore, the present inventors confirmed the increased expression of VEGF, KGF, IGF after treatment of the isolated golden papilla cells.
본 발명의 발명자들은 황금 추출물의 상기와 같은 탈모방지 및 발모촉진 효 과를 확인하기 위하여, 생후 2 일된 랫트로부터 직접 분리한 모유두세포를 이용하여 인바이트로(in vitro) 실험에서 다음과 같은 방법을 사용하였다.The inventors of the present invention, in order to confirm the hair loss prevention and hair growth promoting effect of the golden extract, using the following method in vitro experiments using the dermal papilla cells directly isolated from rats 2 days old. It was.
1) 모유두세포의 분리1) Isolation of dermal papilla cells
2) RT-PCR을 통한 VEGF, KGF, IGF의 발현 증가 측정.2) Measurement of increased expression of VEGF, KGF and IGF via RT-PCR.
이와 같은 시험법들은 인비보(in vivo) 시험법에 앞서 활용할 수 있는 인바이트로(in vitro) 검색법으로서 매우 유용하다.Such assays are very useful as in vitro screening methods that can be utilized prior to in vivo assays.
다음으로 본 발명의 실시예를 설명한다.Next, an embodiment of the present invention will be described.
본 발명의 발명자들은 다음과 같은 순서로 실험을 진행하였다.The inventors of the present invention conducted the experiment in the following order.
1) 황금추출물의 제조1) Preparation of Golden Extract
2) 모유두 세포의 분리 및 확인2) Isolation and identification of dermal papilla cells
3) RT-PCR을 통한 VEGF, KGF, IGF 발현 측정3) VEGF, KGF, IGF expression measurement by RT-PCR
이하 본 발명의 실험 내용을 상세히 설명한다. Hereinafter, the experimental content of the present invention will be described in detail.
1. 추출물의 제조1. Preparation of Extract
건조된 황금 1kg에 5배가량의 물로 열추출하여 여과하고 여액을 감압 농축 후 72시간 동결 건조하였다. 황금 열 수추출물은 PBS(Phosphate buffered saline)를 사용하여 최종 농도 10㎎/㎖가 되도록 용해하였고 필터(0.22㎛ pore size, Millipore)로 여과 멸균하여 사용하였다.Filtration was carried out by heat extraction with 5 times of water to 1kg of dried golden gold, and the filtrate was concentrated under reduced pressure and freeze-dried for 72 hours. The golden hot water extract was dissolved in PBS (Phosphate buffered saline) to a final concentration of 10 mg / ml and filtered and sterilized with a filter (0.22 μm pore size, Millipore).
2. 모유두세포의 분리 및 확인2. Isolation and identification of dermal papilla cells
모유두세포의 분리는 생후 2일 된 랫트 피부조직을 시료로 하여 실시되었다. 상기 시료를 해부칼로 분쇄한 후 1㎎/㎖의 교원질(膠原質) 분해 효소(collagenase) I 용액을 첨가하여 4시간 동안 37℃ 배양기에서 회전시키면서 반응시켰다. 반응이 끝난 조직용액으로부터 세포가 분리될 수 있도록 1분간 송풍시킨 후 30분간 실온에서 정치하였다. 이후 상층액을 Histopaque 1083 용액 5㎖ 위에 조심스럽게 올려준 후 2500rpm 속도에서 20분간 원심분리를 시행하였다. Separation of dermal papilla cells was carried out using a sample of rat skin tissue 2 days old. The sample was pulverized with a dissecting knife and then reacted while rotating in a 37 ° C. incubator for 4 hours with the addition of 1 mg / ml collagenase I solution. The cells were blown for 1 minute to separate the cells from the finished tissue solution and allowed to stand at room temperature for 30 minutes. Then, the supernatant was carefully placed on 5 ml of Histopaque 1083 solution and centrifuged for 20 minutes at 2500 rpm.
원심분리후 중간세포층을 취하여 15% fetal bovine serum이 포함된 DMEM (Dulbecco's modified Eagle's medium)에 넣고 5% CO2, 37oC의 조건하에서 배양하였다. After centrifugation, the intermediate cell layer was taken and placed in DMEM (Dulbecco's modified Eagle's medium) containing 15% fetal bovine serum and incubated under conditions of 5% CO 2 and 37 ° C.
분리후 처음 5일간은 관찰하지 않은채로 두고, 이후부터는 2일마다 배지를 교환하였다. 일차배양에서 배양접시에 충만해질때 모유두세포를 0.25% 트립신을 처리하여 채취하고 단일세포현탁액으로 계대 배양하였다. The first 5 days after separation were left unobserved, and the medium was changed every 2 days thereafter. When primary cultures were filled with culture plates, dermal papilla cells were harvested with 0.25% trypsin and subcultured with single cell suspension.
일부 세포는 생화학적 확인을 위하여 alkaline phosphatase assay를 시행하였으며(도 1), total RNA를 추출하여 모유두세포 특이적 유전자의 발현을 RT-PCR 방법을 사용하여 확인하였다(도 2). Some cells were subjected to alkaline phosphatase assay for biochemical identification (FIG. 1), and the expression of the dermal papilla cell-specific genes was confirmed by extracting total RNA using the RT-PCR method (FIG. 2).
도 1은 분리한 모유두세포의 alkaline phosphatase 활성도 측정결과를 나타내는 도면이고, 도 2는 분리한 모유두세포의 유전자발현조사결과를 나타내는 도면이다.1 is a view showing the results of alkaline phosphatase activity measurement of isolated dermal papilla cells, Figure 2 is a view showing the results of the gene expression of the isolated dermal papilla cells.
모유두세포에서는 Alkaline phosphatase 활성이 매우 높은 것으로 이미 알려진바, 본 발명자들이 분리한 세포가 모유두세포인지 확인하기 위하여 분리한 모유 두세포(DP로 표기)와 대조군으로서는 유사한 모양을 가지는 섬유아세포인 CHO (chineses hamster ovary cell)과 피부세포일종인 melanocyte B16BL6을 설정하여 세가지 세포에서 효소활성을 측정하였다. 측정결과 도 1에서 알 수 있는 바와 같이, CHO 세포보다는 30배, melanocyte에서보다는 10배 강한 효소활성을 나타내었다.Alkaline phosphatase activity is already known to be very high in dermal papilla cells. In order to confirm whether the isolated cells are dermal papilla cells, the isolated dermal papilla cells (denoted DP) and fibroblasts having a similar shape as a control group (chineses) hamster ovary cell) and melanocyte B16BL6, a kind of skin cell, were set up and enzyme activity was measured in three cells. As can be seen in Figure 1, the enzyme activity was 30 times stronger than CHO cells, 10 times stronger than in melanocytes.
또 모유두세포에서는 Versican과 Nexin 유전자가 특징적으로 발현되는 것으로 알려져있다. It is also known that Versican and Nexin genes are characteristically expressed in dermal papilla cells.
따라서 본 발명자들이 분리한 세포가 모유두세포인지 확인하기 위하여 분리한 모유두세포(DP로 표기)와 대조군으로서는 유사한 모양을 가지는 섬유아세포인 CHO(chineses hamster ovary cell) 을 설정하여 두 세포에서 유전자발현을 조사하였다. Therefore, the present inventors set up CHO (chineses hamster ovary cells), which are fibroblasts with similar shapes as control cells, to identify whether the cells are separated from the dermal papilla cells, and investigate gene expression in the two cells. It was.
조사결과 도 2에 도시된 바와 같이, CHO 세포와 DP 세포에서 Actin 유전자는 동일하게 발현되었으며, 모유두세포의 유전자 마커인 Nexin과 Versican 유전자는 본 발명자들이 분리한 모유두세포에서만 발현되었다.As shown in FIG. 2, Actin genes were identically expressed in CHO cells and DP cells, and Nexin and Versican genes, which are gene markers of dermal papilla cells, were expressed only in the dermal papilla cells isolated by the present inventors.
3. 모유두세포에서의 RT-PCR3. RT-PCR in dermal papilla cells
상기 2에서 언급한 바와 같이 분리하여 확인한 모유두 세포을 선정하고 5x105 cells/well의 농도로 6-well culture plate에 seeding한 후, 세포의 conflucency가 약 80~90%가 될 때까지 배양한다. 배양한 세포에 황금 추출물을 50㎍/㎖의 농도로 처리하였다. As mentioned in 2 above, isolate and identify the dermal papilla cells identified and seeded on a 6-well culture plate at a concentration of 5x105 cells / well, and incubate until the cell's conflucency is about 80-90%. The cultured cells were treated with a gold extract at a concentration of 50 μg / ml.
세포를 배양할 때에는 15% serum(FBS)과 antibiotics(penicillin)가 모두 첨 가된 DMEM 배지를 사용하였으며, 물질처리 시에는 5% serum(FBS)이 첨가되지 않은 RPMI1640 배지를 사용하였다. 물질 처리한 지 24시간 후, 세포를 회수하여 세포의 total RNA를 추출하였다. 추출한 RNA로 RT-PCR을 수행하고 그 생성물을 전기영동으로 확인해 봄으로써, VEGF와 KGF, IGF의 유전자 발현 정도를 측정하였다. When culturing cells, DMEM medium containing both 15% serum (FBS) and antibiotics (penicillin) was used, and RPMI1640 medium without 5% serum (FBS) was used for material treatment. 24 hours after the material treatment, the cells were collected and the total RNA of the cells was extracted. RT-PCR was performed on the extracted RNA and the product was confirmed by electrophoresis, thereby measuring gene expression levels of VEGF, KGF, and IGF.
이렇게 모유두세포의 성장에 영향을 주는 성장인자 및 마커 유전자의 발현을 측정해 봄으로써, 발모를 직접적으로 촉진시킬 수 있는 효과를 나타내는 한국 천연자생식물을 스크리닝할 수 있었다. By measuring the expression of growth factors and marker genes affecting the growth of dermal papilla cells, Korean native plants that have the effect of directly promoting hair growth could be screened.
스크리닝 결과, 황금 추출물을 처리한 세포의 RNA에서 VEGF와 KGF, IGF의 발현이 뚜렷이 증가한 것을 확인할 수 있었다. As a result of the screening, it was confirmed that the expression of VEGF, KGF, and IGF was markedly increased in RNA of the cells treated with the golden extract.
또한 양성대조군으로서 minoxidil을 처리한 세포에서보다 더 크게 황금 추출물이 모유두 세포 및 상피세포의 성장인자와 세포외기질 단백질 유전자의 발현을 촉진시키는 것을 확인할 수 있었다. 이로써 도 3에 도시된 바와 같이, 결과적으로 황금추출물을 발모조직인 모유두세포에 직접적으로 작용하여 세포생장을 촉진시키는 것으로 예상되었다. In addition, it was confirmed that the gold extract promoted the expression of growth factors and extracellular matrix protein genes of dermal papilla cells and epithelial cells more significantly than that of minoxidil-treated cells. As a result, as shown in Figure 3, as a result, the golden extract was expected to directly act on the dermal papilla cells of the hair growth tissue to promote cell growth .
또 도 3에서 알 수 있는 바와 같이, 황금추출물 처리 시, 혈관확장과 관련있는 성장인자인 VEGF와 각질세포성장인자인 KGF, 인슐린유사성장인자인 IGF의 발현이 대조군에 비하여 증가되었으며, 양성대조군인 Minoxidil 처리군에서보다 효능이 더 뛰어남을 확인할 수 있었다. 도 3은 모유두세포에서의 유전자발현 측정결과를 나타내는 도면이다. 도 3에서 Control은 추출물을 처리하지 않은 대조군이고, Sample은 황금추출물 처리군이다.In addition, as can be seen in Figure 3, during the golden extract treatment, growth factors related to vascular expansion, VEGF, keratinocyte growth factor KGF, insulin-like growth factor IGF expression was increased compared to the control group, positive control It was confirmed that the efficacy was superior to that in the minoxidil treatment group. 3 is a diagram showing the results of gene expression measurement in dermal papilla cells. In Figure 3 Control is not treated with the extract control, Sample is a gold extract treated group.
VEGF의 경우 황금추출물을 처리하였을때 1.83 배 증가하여 2배 증가된 Minoxidil과 유사한 양상으로 유전자 발현이 증가되었음을 확인하였으며, KGF는 2.77배 증가되어 약 2배 증가된 Minoxidil보다 성장인자 발현에 효과적임이 입증되었다. IGF는 Minoxidil 처리군에서 1.36배 발현이 증가되었으나 황금추출군에서는 1.73배 증가되었다.In the case of VEGF, the gene expression was increased by 1.83-fold increase and 2-fold increase of Minoxidil when treated with gold extract, and KGF was increased by 2.77-fold, which proved more effective in the growth factor expression than Minoxidil, which was increased about 2 times. It became. IGF increased 1.36-fold in the Minoxidil-treated group, but increased 1.73-fold in the golden extract group.
이상 본 발명자에 의해서 이루어진 발명을 상기 실시예에 따라 구체적으로 설명하였지만, 본 발명은 상기 실시예에 한정되는 것은 아니고 그 요지를 이탈하지 않는 범위에서 여러 가지로 변경 가능한 것은 물론이다.As mentioned above, although the invention made by this inventor was demonstrated concretely according to the said Example, this invention is not limited to the said Example and can be variously changed in the range which does not deviate from the summary.
상술한 바와 같이, 본 발명에 따른 황금추출물 및 그를 주성분으로 하는 발모촉진제, 그리고 발모촉진 효과 유무의 검사 방법에 의하면, 발모조직인 모유두세포의 생장을 촉진시킴으로써 탈모를 방지하고 발모를 촉진시킬수 수 있다는 효과가 얻어진다.As described above, according to the golden extract according to the present invention and the hair growth promoting agent having a main component thereof, and the test method of the hair growth promoting effect, it is possible to prevent hair loss and promote hair growth by promoting the growth of dermal papilla cells, which are hair growth tissues. Is obtained.
또, 본 발명에 따른 황금추출물 및 그를 주성분으로 하는 발모촉진제, 그리고 발모촉진 효과 유무의 검사 방법에 의하면, 천연식물로부터 유래되어 인체에 해가 없는 발모제 소재를 획득하는 것이 가능하고, 발모촉진의 효과 유무를 알 수 있다는 효과가 얻어진다In addition, according to the golden extract according to the present invention, the hair promoter having a main component thereof, and the inspection method of the hair growth promoting effect, it is possible to obtain a hair regrowth material derived from natural plants and harmless to the human body, and the effect of hair growth promoting The effect of knowing the presence or absence is obtained
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060044961A KR20070111765A (en) | 2006-05-19 | 2006-05-19 | Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060044961A KR20070111765A (en) | 2006-05-19 | 2006-05-19 | Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20070111765A true KR20070111765A (en) | 2007-11-22 |
Family
ID=39090524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060044961A KR20070111765A (en) | 2006-05-19 | 2006-05-19 | Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20070111765A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130094089A (en) * | 2012-02-15 | 2013-08-23 | (주)아모레퍼시픽 | Composition containing scutellaria baicalensis extract and vinegars for scalp or hair |
CN104095784A (en) * | 2014-06-27 | 2014-10-15 | 广西大学 | Anti-dandruff and antipruritic shampoo |
KR101451337B1 (en) * | 2013-06-10 | 2014-10-22 | 신어진 | Method of making hair restorer composition |
-
2006
- 2006-05-19 KR KR1020060044961A patent/KR20070111765A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130094089A (en) * | 2012-02-15 | 2013-08-23 | (주)아모레퍼시픽 | Composition containing scutellaria baicalensis extract and vinegars for scalp or hair |
KR101451337B1 (en) * | 2013-06-10 | 2014-10-22 | 신어진 | Method of making hair restorer composition |
CN104095784A (en) * | 2014-06-27 | 2014-10-15 | 广西大学 | Anti-dandruff and antipruritic shampoo |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5850929B2 (en) | Composition for improving the appearance of the skin by stimulating MAGP-1 | |
CN103520014B (en) | Dermatologic preparation composition containing the Ginsenoside F2 from hydroponic culture ginseng | |
CN110312551B (en) | Cosmetic composition containing royal jelly of wasp's black bee | |
KR100853761B1 (en) | Extract of Stewartia koreana and Use Thereof | |
WO2016021872A1 (en) | External skin preparation composition containing herbal medicine extract, for preventing hair loss and promoting hair growth | |
US9458429B2 (en) | Mesenchymal stem cell attractant and method for attracting mesenchymal stem cell | |
Di Martino et al. | Hibiscus syriacus extract from an established cell culture stimulates skin wound healing | |
US20150374605A1 (en) | Use of a composition comprising avocado perseose in the protection of epidermal stem cells | |
JP2018512440A (en) | Cell-free plant cell culture suspension supernatant having rejuvenation activity and / or wound healing activity on skin cells | |
CN104987358B (en) | A kind of preparation method of pilose antler protein extract | |
JP3555030B2 (en) | Cosmetic or medicinal and in particular dermatological composition containing an extract of the genus Tefrusia, in particular the Tephrus spp. | |
KR20070111765A (en) | Extract of scutellariae and hair growing promotor as a main ingredient thereof, and detecting method of hair growing | |
KR102615361B1 (en) | Use of matrix cells for preparing a micro hair follicle | |
EP2561858B1 (en) | A composition for activating hair follicle stem cells to stimulate hair growth | |
CN104987359B (en) | A kind of pilose antler protein extract and its application, pharmaceutical preparation | |
KR20040029451A (en) | Hair follicle-reconstitution system and animal carrying the same | |
KR101953257B1 (en) | Composition for preventing hair loss and growing hair comprising tulip, saw palmetto, nettle extracts | |
KR101114307B1 (en) | Hair growth agent composition | |
CN110393697A (en) | A kind of jelly peptide essence and preparation method thereof | |
KR20170098145A (en) | Cosmetic composition containing stellera chamaejasme extract or fraction thereof and use thereof | |
KR20150085991A (en) | Skin whitening compositions containing oriental medicine natural herb | |
KR20140148227A (en) | Composition for preventing depilation and hair growth promotion and Method of preparing thereof | |
Thamizharasan et al. | Pharmacognostical study of Bambusa arundinacea seeds | |
KR20070105755A (en) | Schizonepeta tenuifolia briquet extracts, hair restorer containing the schizonepeta tenuifolia briquet extracts, and test method determining whether obesity is prevented | |
JP7465589B2 (en) | Serine palmitoyltransferase mRNA expression promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |